Invictus MD Builds Canadian LP Portfolio

Exclusive Interview with Dan Kriznic, CEO Invictus MD Strategies (TSXV: IMH) (OTC: IVITF) (FRA: 8IS) announced its entry into Canada’s medical cannabis production market through its 1/3 acquisition of...
- April 5th, 2017 at 1:04 pm

United Greeneries Harvests First Crop

First Cannabis Crop Harvested at Duncan Facility 5 April 2017 First crop of OG Kush strain successfully harvested at Duncan Facility yielding approximately 60kg of dried cannabis buds Cannabis...
- April 5th, 2017 at 7:45 am

Gateway Cannabis Accelerator Completes Second Class

Second Group of Gateway Graduates Are First to Take on Market After Passing of California’s Prop 64 GTWY 02 Welcomes Investors and Media to Graduation of Cannabis-Technology and Consumer...
- April 4th, 2017 at 9:04 am

GrowGeneration Generates $8m Sales in 2016

GrowGeneration Achieves Record 2016 Sales, Up 130% DENVER, April 3, 2017 /PRNewswire/ — GrowGeneration Corp. (OTC: GRWG),  (“GrowGen” or the “Company”) one of the largest specialty retail hydroponic and organic gardening...
- April 3rd, 2017 at 10:30 am

Horizons Medical Marijuana ETF to Debut April 5th

Let’s face it, when it comes to cannabis stocks, Canada continues to crush the United States, where federal illegality makes it more difficult to operate and to raise capital....
- April 2nd, 2017 at 11:14 pm

Terra Tech Expects 2017 Sales of $38-40mm

  After the close of business Friday, Terra Tech (OTC: TRTC) issued a press release, filed its 10-K and hosted a conference call (replay) to discuss 2016 results and...
- April 2nd, 2017 at 7:08 pm

Cannabis Real Estate Draws Investors as Prices Surge

The hot topic at the Institutional Cannabis & Capital Conference in San Jose this week was real estate. While institutional investors are unlikely to invest directly in cannabis production...
- April 1st, 2017 at 9:39 am

Arizona Cannabis Operator BCC Raises Another $20mm

BCC Announces $20 Million Private Placement of Common Shares TORONTO, ON / ACCESSWIRE / March 30, 2017 / The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE: BCC, OTC:...
- March 31st, 2017 at 8:03 am

Surna Posts 20% Sales Growth in Q4

Surna Inc. Reports Fourth Quarter and Year-end 2016 Financial Results – Grew revenue 20% and 72%, compared to Q4 2015 and Q3 2016, respectively – Strengthened balance sheet by...
- March 31st, 2017 at 7:40 am